Bionano Genomics, Inc. Stock price
Equities
BNGO
US09075F3055
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.11 USD | +1.83% | +5.71% | -41.27% |
Financials (USD)
Sales 2024 * | 38.74M | Sales 2025 * | 50.93M | Capitalization | 59.62M |
---|---|---|---|---|---|
Net income 2024 * | -87M | Net income 2025 * | -69M | EV / Sales 2024 * | 1.54 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.17 x |
P/E ratio 2024 * |
-0.58
x | P/E ratio 2025 * |
-0.86
x | Employees | 344 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.52% |
Latest transcript on Bionano Genomics, Inc.
1 day | +4.81% | ||
1 week | +3.81% | ||
Current month | -12.80% | ||
1 month | -16.15% | ||
3 months | -48.10% | ||
6 months | -62.80% | ||
Current year | -42.33% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Holmlin
CEO | Chief Executive Officer | 56 | 11-01-11 |
Gülsen Kama
DFI | Director of Finance/CFO | 51 | 23-09-10 |
Shroff Hema
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 64 | 18-06-30 | |
David Barker
CHM | Chairman | 82 | 10-05-10 |
Albert Luderer
BRD | Director/Board Member | 75 | 11-09-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 8 M€ | +9.29% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 1.11 | +1.83% | 1 717 941 |
24-03-27 | 1.09 | +4.81% | 1,742,588 |
24-03-26 | 1.04 | +0.97% | 737,761 |
24-03-25 | 1.03 | -0.96% | 1,249,009 |
24-03-22 | 1.04 | -1.89% | 707,114 |
Delayed Quote Nasdaq, March 27, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-42.33% | 59.62M | |
+9.15% | 221B | |
+18.60% | 142B | |
+18.70% | 101B | |
+7.98% | 68.07B | |
+24.79% | 57.27B | |
-2.49% | 47.42B | |
+6.00% | 43.19B | |
+16.80% | 41.12B | |
+14.13% | 28.84B |